Active & Intelligent Packaging in Pharmaceutical Market Size (2024 - 2029)

The Active & Intelligent Packaging in Pharmaceutical Market is experiencing significant growth driven by the increasing demand for smart packaging solutions that ensure product safety and connectivity. This growth is fueled by the need to address challenges such as counterfeit drugs and the preservation of drug integrity, which are critical due to the sensitivity of pharmaceuticals to temperature and time. Advances in technology, particularly in printed electronics, are enhancing the market's potential by reducing costs, although rising pharmaceutical prices and consumer reluctance pose challenges. The market's expansion is also influenced by the ongoing disruptions in supply chains and the need for pharmaceutical companies to adapt their business processes, particularly in response to the COVID-19 pandemic.

Market Size of Active & Intelligent Packaging in Pharmaceutical Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
9
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 9.00 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Active & Intelligent Packaging in Pharmaceutical Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Active and Intelligent Packaging in Pharmaceutical Market Analysis

The Active & Intelligent Packaging in Pharmaceutical Market is expected to grow at a CAGR of 9% over the forecast period 2020 to 2025. With remarkably many data-driven and AI-oriented and trending technologies already influencing the status of the logistics and packaging market, the global pharmaceutical industry gets roped in with them all to produce overall better outcomes. Owing to connectivity and product safety, drug, healthcare, pharmaceutical, and biopharmaceutical organizations are investing a lot in smart packaging solutions. Since temperature and time affect the overall condition of drugs and medicines, the necessity to have an effective and intelligent packaging system is of topmost priority. This is becoming a significant growth driver for the overall pharmaceutical packaging industry.

  • Near field communication (NFC) exhibits profitable and tolerable use cases in Pharmaceutical. NFC was required in pharmaceuticals, as a report by the World Health Organization (WHO) in 2019, reveals that even today, counterfeit drugs account for 8-15% of all pharmaceutical and drug products retailed globally. Using NFC, customers can scan for the authentication of products and check their legitimacy, validity, history, and dose instructions before consuming.
  • Market demand has been growing for Active & Intelligent Packaging solutions that not only protect products from unwanted moisture and oxygen ingress but also proactively remove moisture and gases within the package headspace, as well as reactive impurities and off-gassing from increasingly sophisticated, costly and valuable OSD products.
  • Aptar CSP Technologies has introduced a couple of solutions. For instance, for bottles, Activ-Seal closures feature gas-scavenging and moisture-scavenging technologies built directly into an induction-sealed, tamper-evident screw cap. For blisters, Activ-Blister solutions control each cavity's internal atmosphere, providing desiccant and scavenging capabilities to traditional and existing blistering films and design, negating the need for purging or secondary packaging.
  • The Active & Intelligent Packaging in Pharmaceutical Market is, therefore, witnessing a remarkable growth. Advances in printed electronics are boosting the potential opportunities for Active & intelligent packaging by lowering costs. Whereas, significant challenges are rising prices of the pharmaceuticals, lack of willingness from consumers and retailers, and lack of marketing acting as a major restraint for the growth of the market.
  • Presently, pharmaceutical businesses are reacting to the prompt challenges resulting from the disruption in supply chains and the necessity to change business processes. If the current COVID-19 pandemic persists for a medium or long time, it may influence the supply of active material and ingredients (mainly from China), as well as the import and export of pharmaceuticals. There is also the potential for contradictory impacts of both a medium and longer-term nature on R&D and manufacturing projects, as well as the delay on projects or programs not related to the core supply chain/data management operations.

Active and Intelligent Packaging in Pharmaceutical Industry Segmentation

Active and intelligent packaging involving ground-breaking technologies such as corrosion control packaging, gas scavengers, susceptor packaging, moisture control packaging, thermochromic ink packaging, time-measured indicators, temperature-oriented indicators, NFC components, QR codes, RFID ICS, and so on. Advancements in active and intelligent packaging technologies are helping to ensure that oral solid dose (OSD) drug delivery - which comprises both capsules and tablets and remains the most popular delivery method.

Active Packaging
Oxygen Scavengers
Microwave Susceptors
Odor Absorbers/Emitters
Moisture/ Humidity Absorbers
Anti-microbial Packaging
Others Active Packagings (Pure Absorbers and Carbon Emitters)
Intelligent Packaging
Coding and Marking
Sensors & Devices (Time-Temperature Indicators (TTIs))
RFID & NFC
Other Intelligent Packaging
Geography
North America
United States
Canada
Europe
United Kingdom
Germany
France
Rest of Europe
Asia Pacific
China
India
Japan
Rest of Asia Pacific
Latin America
Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Active & Intelligent Packaging in Pharmaceutical Market Size Summary

The Active & Intelligent Packaging in Pharmaceutical Market is experiencing significant growth, driven by the integration of data-driven and AI-oriented technologies within the pharmaceutical logistics and packaging sectors. This growth is largely attributed to the increasing investments by drug, healthcare, pharmaceutical, and biopharmaceutical organizations in smart packaging solutions that ensure product safety and connectivity. The necessity for effective packaging systems is underscored by the impact of temperature and time on the condition of drugs and medicines, making intelligent packaging a top priority. The market is further bolstered by the demand for solutions that protect products from moisture and oxygen ingress, as well as those that utilize technologies like Near Field Communication (NFC) and Radio-frequency Identification (RFID) to enhance product authentication and logistics operations.

In North America, particularly the United States, the market is witnessing accelerated growth due to stringent regulations and increased health awareness, which have heightened the demand for advanced packaging systems. The region's pharmaceutical industry plays a crucial role in the active and intelligent packaging market, with significant contributions from major players like BASF, Amcor Ltd, and Honeywell International Inc. These companies are expanding their presence through strategic mergers and acquisitions, as well as collaborations to enhance packaging solutions. The market remains fragmented, with intense competition among smaller firms aiming to capitalize on the high-growth potential. Innovations such as Aptar CSP Technologies' Activ-Seal and Activ-Blister solutions, along with advancements in printed electronics, are driving the market forward, despite challenges like rising pharmaceutical prices and supply chain disruptions.

Explore More

Active & Intelligent Packaging in Pharmaceutical Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Industry Value Chain Analysis

    3. 1.3 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.3.1 Bargaining Power of Suppliers

      2. 1.3.2 Bargaining Power of Consumers

      3. 1.3.3 Threat of New Entrants

      4. 1.3.4 Threat of Substitutes

      5. 1.3.5 Intensity of Competitive Rivalry

    4. 1.4 Market Drivers

      1. 1.4.1 Advancements in Pharmaceutical Packaging Industry

    5. 1.5 Market Restraints

      1. 1.5.1 High Initial Cost for Research Activities

    6. 1.6 Market Opportunities

    7. 1.7 Assessment of Impact of Covid-19 on the Industry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Active Packaging

      1. 2.1.1 Oxygen Scavengers

      2. 2.1.2 Microwave Susceptors

      3. 2.1.3 Odor Absorbers/Emitters

      4. 2.1.4 Moisture/ Humidity Absorbers

      5. 2.1.5 Anti-microbial Packaging

      6. 2.1.6 Others Active Packagings (Pure Absorbers and Carbon Emitters)

    2. 2.2 Intelligent Packaging

      1. 2.2.1 Coding and Marking

      2. 2.2.2 Sensors & Devices (Time-Temperature Indicators (TTIs))

      3. 2.2.3 RFID & NFC

      4. 2.2.4 Other Intelligent Packaging

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

      2. 2.3.2 Europe

        1. 2.3.2.1 United Kingdom

        2. 2.3.2.2 Germany

        3. 2.3.2.3 France

        4. 2.3.2.4 Rest of Europe

      3. 2.3.3 Asia Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 India

        3. 2.3.3.3 Japan

        4. 2.3.3.4 Rest of Asia Pacific

      4. 2.3.4 Latin America

      5. 2.3.5 Middle East and Africa

Active & Intelligent Packaging in Pharmaceutical Market Size FAQs

The Active & Intelligent Packaging in Pharmaceutical Market is projected to register a CAGR of 9% during the forecast period (2024-2029)

BASF SE, Amcor Ltd, Honeywell International Inc., Landec Corporation and Crown Holdings Inc. are the major companies operating in the Active & Intelligent Packaging in Pharmaceutical Market.

Active & Intelligent Packaging in Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)